IP Verse

E R Squibb & Sons patent opposition analysis

Get complete Patent Opposition Report for E R Squibb & Sons

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest patents of E R Squibb & Sons opposed by its competitors

Explore E R Squibb & Sons's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3597216Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof5
EP2905030Nov 6, 2019Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof1
EP2439273Feb 27, 2019Human Monoclonal Antibodies To Programmed Death 1(Pd-1) And Methods For Treating Cancer Using Anti-Pd-1 Antibodies Alone Or In Combination With Other Immunotherapeutics1
EP2501822Aug 16, 2017Methods For Enhanced Protein Production2